[email protected] | 833-399-3799 Returns Returns are accepted within 30 days of purchase on all products, as long as the item is sealed, unopened, and in its original packaging
Abida Sardar Meet Dr
Key Benefits Observed in Clinical Trials Treatment of Erythropoietic Protoporphyria (EPP): MT-1 (Afamelanotide) is FDA-approved for use in patients with EPP, a rare genetic disorder that causes extreme photosensitivity, leading to severe pain and skin damage upon light exposure
BPC-157 500mcg + KPV 500mcg per unit Third-party tested batch documentation included USA tested and fulfilled For laboratory research use only BPC-157 and KPV Capsule (500mcg/500mcg) Research Overview BPC-157 and KPV (500mcg/500mcg) is a research-grade dual-peptide formulation combining BPC-157, a synthetic pentadecapeptide originally isolated from gastric juice protein, with KPV, a tripeptide derived from the C-terminal sequence of alpha-MSH
Store reconstituted vials properly (refrigerated, protected from light), and respect expiration dates to ensure potency and sterility